west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "平阳霉素" 4 results
  • 平阳霉素瘤体内注射治疗牙龈瘤52例的临床疗效观察

    摘要:目的:观察平阳霉素瘤体内注射治疗牙龈瘤并保留牙龈瘤所波及的活髓牙齿的临床疗效。方法:选择牙龈瘤患者171例,采用随机分组方法,选择52例平阳霉素瘤体内注射治疗为观察1组,48例微波治疗为观察2组, 71例手术切除治疗为对照组,分别观察临床治愈疗效、复发等情况。结果:观察1组临床治愈率100%;观察2组临床治愈率89.6%;对照组临床治愈率83.1%;观察1组治愈率高于对照组、观察2组。结论:平阳霉素瘤体内注射治疗应用于治疗牙龈瘤并保留牙龈瘤所波及的活髓牙齿创伤性小、方便易掌握,且效果可靠,无复发,对人体无不良影响,操作技术要求不高,更适合于基层推广应用。

    Release date:2016-08-26 03:57 Export PDF Favorites Scan
  • CLINICAL ANALYSIS OF 55 CASES OF HEMANGIOMA IN SUPERFICIAL BODY TREATED WITH COPPERNEEDLES

    To analyze the cl inical effect of retained copper needles well as neoplasm l igation, retained copper needles associated with Pingyangmycin injection and inserted copper needles followed by DC in treating hemangiomaso as to treat hemangioma with copper needles. Methods From January 1999 to January 2006, 55 cases of hemangioma in superficial body were treated with copper needles, including 28 males and 27 females and aging 3-50 years(median 19 years). There were 42 cases of cavernous hemangiomas, 4 cases of racemose hemangiomas and 9 cases of multipl icate hemangiomas. The size ranged from 6 cm × 4 cm to 40 cm × 25 cm. Retaining copper needles were used in 29 cases, retaining copper needles with l igating neoplasm in 21 cases, retaining copper needles associated with Pingyangmycin injection in 3 cases and inserting copper needles followed by DC in 2 cases. Results Fifty cases were treated with copper needles only once and 5 cases twice. All cases were followed up for three to eighteen months. According to Wang Yongjie’s criterion, 15 (27.3%) cases were cured, 38 (69.1%) improved, and 2(3.6%)failed to respond; the response rate was 96.4% (53). Conclusion Copper needle is efffective for treating hemangioma in superficial body. Retaining copper needles with l igation neoplasm or with Pingyangmycin injection can achieve better effect.

    Release date:2016-09-01 09:12 Export PDF Favorites Scan
  • Clinical Analysis of Pingyangmycin in Treatment of Body Surface Hemangioma in Children (Report of 1 658Cases)

     Objective To evaluate the therapeutic effects of pingyangmycin in treatment of body surface hemangioma in children.  Methods The clinical data of 1 658 children patients with hemangioma on body surface in which pingyangmycin was injected between January 1997 and January 2008 were analyzed retrospectively.  Results All 1 658 patients were observed for 6-12 months, with average of 10.83 months. The total effective rate was 97.09%. Compared among different types of hemangioma, total effective rate had significant difference (χ2=203.12, P<0.01), and complete remission (CR) rate had significant difference (χ2=287.97, P<0.01). The therapeutic effect of pingyangmycin in treatment of cavernous hemangioma was better than that of strawberry hemangioma, mixed hemangioma and portwine stain, which was better instrawberry hemangioma than mixed hemangioma and portwine stain, and which was lower in portwine stain than other hemangiomas. Fifty-four patients (3.26%) caught partial necrotic ulcer of hemangioma. There were 418 cases (25.21%) of fever and 3 cases (0.18%) of allergic shock.  Conclusion Intratumorally pingyangmycin injection is a simple, safe and effective therapy for hemangioma of body surface in children.

    Release date:2016-09-08 10:57 Export PDF Favorites Scan
  • Analysis of Clinical Curative Effect of Personalized Interventional Therapy on Hepatic Cavernous Hemangioma

    ObjectiveTo explore the clinical efficacy of transcatheter arterial embolization or transcatheter arterial embolization combined with percutaneous transhepatic sclerotherapy injection for hepatic cavernous hemangioma with different blood supply. MethodsEighty-six patients with hepatic cavernous hemangioma with different blood supply received femoral artery pingyangmycin iodized oil embolization or transcatheter arterial embolization combined with percutaneous transhepatic injection of pingyangmycin iodized oil embolization from February 2004 to April 2013. ResultsForty-five cases (52.3%) of tumor decreased by over 50%; 26 (30.2%) decreased by about 20% to 50%; 11 (12.8%) decreased by less than 20%; and 4 (4.7%) had no significant change in the tumor diameter. Patients did not have serious complications. ConclusionThe effect of individualized intervention for hepatic cavernous hemangioma with different blood supply is obvious, and it is a safe and effective therapeutic method.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content